Heron Therapeutics | HRTX - Ordinary Share Capital


Heron Therapeutics reported $1.52M in Ordinary Share Capital for its fiscal quarter ending in September of 2024.





Ordinary Share Capital Change Date
ALKERMES USD 165.61M 503K Dec/2025
Alnylam Pharmaceuticals USD 132.38M 585K Dec/2025
Amarin USD 20.8M 28K Sep/2025
ANI Pharmaceuticals USD 22.49M 760K Dec/2025
Anika Therapeutics USD 143K 1000 Mar/2025
Arrowhead Research USD 135.7M 2.44M Sep/2025
Eisai JPY 282.11M 1000 Dec/2025
Emergent BioSolutions USD 100K 0 Jun/2023
Esperion Therapeutics USD 112K 11K Sep/2023
GlaxoSmithKline GBP 4.08B 49.43M Dec/2025
Heron Therapeutics USD 1.52M 14K Sep/2024
Insmed USD 214.26M 1.67M Dec/2025
Ligand Pharmaceuticals USD 19.66M 19.64M Sep/2025
Merck USD 2.49B 15.79M Sep/2025
Nektar Therapeutics USD 19K 0 Sep/2024
Neurocrine Biosciences USD 100.1M 400K Dec/2025
Omeros USD 611K 17K Dec/2023
Pacira USD 41.12M 1.85M Dec/2025
Regeneron Pharmaceuticals USD 105.3M 1.1M Sep/2025
Roche Holding CHF 795.62M 699.54K Dec/2025
Surmodics USD 716K 4K Sep/2024
Ultragenyx Pharmaceutical USD 96.44M 88K Sep/2025
Veracyte USD 79.05M 377K Dec/2025
Vertex Pharmaceuticals USD 254M 0 Dec/2025